| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Tarsus Pharmaceuticals, Inc. (TARS) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. TARS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 858.5K | $52.55M | - | |
| Dir | 128.8K | $7.89M | - | |
| COO | 79.2K | $4.85M | - | |
| Other | 47.6K | $2.91M | - | |
| Other | 36.7K | $2.25M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16, 2023 | Neervannan Seshadri | Chief Operating Officer | Sale+OE | 357 | $13.43 | $4,794.51 | -0.6% | +38.5% | +135.3% | |
| Mar 16, 2023 | Greenstein Leonard M. | Chief Financial Officer | Sale+OE | 5,313 | $13.44 | $71,403.59 | -6.9% | +38.5% | +135.3% | |
| Mar 16, 2023 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sale+OE | 8,791 | $13.76 | $120,943.13 | -0.8% | +38.5% | +135.3% | |
| Mar 16, 2023 | Holdbrook Mark J. | V.p., Clinical Affairs | Sale+OE | 187 | $13.43 | $2,511.41 | -5.0% | +38.5% | +135.3% | |
| Mar 9, 2023 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 5,570 | $15.02 | $83,654.23 | -0.3% | +28.2% | +123.5% | |
| Feb 16, 2023 | Greenstein Leonard M. | Chief Financial Officer | Sell | 5,000 | $15.12 | $75,600.00 | -12.7% | +5.3% | +102.9% | |
| Feb 15, 2023 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 8,000 | $15.28 | $122,240.00 | -0.7% | +5.9% | +105.7% | |
| Feb 8, 2023 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 9,000 | $15.14 | $136,260.00 | -0.8% | +6.6% | +106.7% | |
| Jan 23, 2023 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 4,856 | $15.45 | $75,025.20 | -0.4% | -6.8% | +62.9% | |
| Jan 20, 2023 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 8,240 | $14.57 | $120,080.00 | -0.4% | -3.0% | +57.3% |